Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Sol-Gel Technologies Ltd (SLGL)

Sol-Gel Technologies Ltd (SLGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Bullish - green stock market chart with arrow up day trade by Quality Stock Arts via Shutterstock
This Under-the-Radar Stock Has Surged 1,300% Over the Past Year Barchart - Thu Mar 12, 10:55AM CDT

Sol-Gel Technologies (SLGL) is a clinical-stage dermatology company focused on topical drugs for skin diseases. SLGL demonstrates exceptional technical momentum and is up 1,310% over the past 52 weeks....

SLGL : 78.40 (+2.18%)
SLGL Gears Up to Report Q4 Earnings: Here's What You Should Know
SLGL Gears Up to Report Q4 Earnings: Here's What You Should Know Zacks Investment Research - Tue Feb 25, 2025

We expect investors to focus on updates related to Sol-Gel Technologies, Ltd.’s SLGL ability to regain compliance with the recent Nasdaq requirement and other pipeline development activities when it...

MIRM : 96.58 (-2.07%)
SLGL : 78.40 (+2.18%)
PCRX : 23.40 (+0.21%)
Sol-Gel Technologies Approves Mori Arkin as Interim CEO; Provides Update on Clinical Trials and Financial Results Quiver Quantitative, Inc. - Fri Nov 15, 2024

Mori Arkin appointed interim CEO; Sol-Gel reports ongoing clinical trials and recent financial developments.Quiver AI SummarySol-Gel Technologies, Ltd. announced that shareholders approved the appointment...

SLGL : 78.40 (+2.18%)
Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update Globe Newswire - Thu Aug 4, 2022

Prescription volumes to date indicate strong uptake, similar to successful dermatology launches Sol-Gel receives $3.5 million milestone payment from...

SLGL : 78.40 (+2.18%)

Barchart Exclusives

Lowe's Delivers Strong Free Cash Flow, But the Stock Fell - Time to Buy LOW? Barchart - 2 minutes ago
Lowe's Companies delivered strong Q1 free cash flow and is likely to hike its dividend next month. But LOW is down 15% from a recent peak last month and could be worth 35% more at its average historical yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.